The price of Tower Semiconductor Ltd. (NASDAQ:TSEM) went up by $0.45 now trading at $18.11. Their shares witnessed a 33.55% increase from the 52-week low price of $13.56 they recorded on 2018-12-24. Even though it is still -52.46% behind the $27.61 high touched on 2018-05-04. The last few days have been good for the stock, as its price has grew by 3.9% during the week. It has also performed better over the past three months, as it added around 23.53% while it has so far retreated around -30.88% during the course of a year. The stock of TSEM recorded 22.86% uptrend from the beginning of this year till date. The 12-month potential price target for Tower Semiconductor Ltd. is set at $23.25. This target means that the stock has an upside potential to increase by 28.38% from the current trading price.
27 institutions entered new Tower Semiconductor Ltd. (NASDAQ:TSEM) positions, 67 added to their existing positions in these shares, 78 lowered their positions, and 26 exited their positions entirely.
Tower Semiconductor Ltd. (TSEM) trade volume has decreased by -42.58% as around 268,427 shares were sold when compared with its 50-day average volume of traded shares which is 467,474. At the moment, TSEM is witnessing a uptrend, as it is trading 2.22% above its 20-day SMA, 3.94% above its 50-day SMA, and 1.24% above its 200-day SMA. The company runs an ROE of roughly 11.9%, with financial analysts predicting that their earnings per share growth will be around 15% per annum for the next five year. This will be compared to the 20% increase witnessed over the past five years.
The first technical resistance point for Tower Semiconductor Ltd. (NASDAQ:TSEM) will likely come at $18.23, marking a 0.66% premium to the current level. The second resistance point is at $18.34, about 1.25% premium to its current market price. On the other hand, inability to breach the immediate hurdles can drag it down to $17.66, the lower end of the range. TSEM’s 14-day MACD is -0.02 and this negative figure indicates a downward trading trend. The company’s 14-day RSI (relative strength index) score is 58.39, which shows that its stock has been neutral. The 20-day historical volatility for the stock stands at 23.47 percent, which is low when compared to that of the 50-day’s 38.22 percent.
The shares of Cellectis S.A. (NASDAQ:CLLS) has increased by 1.62%, and now trading at $20.11 on the Wall Street in the intra-day deal, with their shares traded now around 84,186. This is a decline of -54,666 shares over the average 138,852 shares that were traded daily over the last three months. The stock that is trading at $20.11 went higher by 31.1% from its 52-week low of $15.34 that it attained back on 2019-01-23. The stock recorded a 52-week high of $31.57 nearly 342 days ago on 2018-05-23.
CLLS stock has performed well over the past 30 days, as it added 10.86% while its price climbed by 20.78% year-to-date (YTD). Looking at the last few days, it has been tough for the stock, as it tumbled -1.18% over the last week. The stock’s 12-month potential target price is now at $41.9. This means that the stock price might likely increase by 108.35% from its current trading price. 7 out of 10 Wall Street analysts which represents 70% rated the stock as a buy while the remaining 30% rated it as a hold, with 0% of analysts rating it as a sell.
Cellectis S.A. (NASDAQ:CLLS) has been utilizing an ROE that is roughly 0%, with stock analysts predicting that the company’s EPS for the next five years will go down by 0% per year, following the -21.2% drop that was witnessed during the past five years. The stock at the moment is on a uptrend, trading 2.42% above its 20-day SMA, 6.89% above its 50-day SMA, and -11.67% below its 200-day SMA. In percentage terms, the aggregate Cellectis S.A. shares held by institutional investors is 30.1%. 11 institutions jumped in to acquire Cellectis S.A. (CLLS) fresh stake, 31 added to their current holdings in these shares, 47 lowered their positions, and 27 left no stake in the company.
The stock’s 9-day MACD is -0.2 and this negative figure indicates a downward trading trend. The company’s 9-day RSI score is 57.96, which shows that its stock has been neutral. The 20-day historical volatility for the shares stand at 26.67 percent, which is less when compared to that of the 50-day’s 39.59 percent. On the daily chart, we see that the stock could reach the first level of resistance at $20.34, sporting a 1.13% premium to the current level. The next resistance point is at $20.57, representing nearly 2.24% premium to the current market price of Cellectis S.A. (CLLS). On the other hand, failure to breach the immediate hurdles can drag it down to $19.61, the lower end of the range.
